FDA.reportPublic FDA data

Application 214420

Type
ANDA
Sponsor
ASCENT PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001POTASSIUM CITRATEPOTASSIUM CITRATETABLET, EXTENDED RELEASE;ORAL5MEQNoNo
002POTASSIUM CITRATEPOTASSIUM CITRATETABLET, EXTENDED RELEASE;ORAL10MEQNoNo
003POTASSIUM CITRATEPOTASSIUM CITRATETABLET, EXTENDED RELEASE;ORAL15MEQNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
31722-129POTASSIUM CITRATEPotassium CitrateCamber Pharmaceuticals, IncANDACurrent
31722-129POTASSIUM CITRATEPotassium CitrateCamber Pharmaceuticals, IncANDACurrent
31722-130POTASSIUM CITRATEPotassium CitrateCamber Pharmaceuticals, IncANDACurrent
31722-130POTASSIUM CITRATEPotassium CitrateCamber Pharmaceuticals, IncANDACurrent
31722-132POTASSIUM CITRATEPotassium CitrateCamber Pharmaceuticals, IncANDACurrent
31722-132POTASSIUM CITRATEPotassium CitrateCamber Pharmaceuticals, IncANDACurrent
43602-399POTASSIUM CITRATEPotassium CitrateAscent Pharmaceuticals IncANDACurrent
43602-400POTASSIUM CITRATEPotassium CitrateAscent Pharmaceuticals IncANDACurrent
43602-401POTASSIUM CITRATEPotassium CitrateAscent Pharmaceuticals IncANDACurrent
72865-191POTASSIUM CITRATEPotassium CitrateXLCare Pharmaceuticals, IncANDACurrent
72865-191POTASSIUM CITRATEPotassium CitrateXLCare Pharmaceuticals, Inc.ANDACurrent
72865-192POTASSIUM CITRATEPotassium CitrateXLCare Pharmaceuticals, IncANDACurrent
72865-192POTASSIUM CITRATEPotassium CitrateXLCare Pharmaceuticals, Inc.ANDACurrent
72865-193POTASSIUM CITRATEPotassium CitrateXLCare Pharmaceuticals, IncANDACurrent
72865-193POTASSIUM CITRATEPotassium CitrateXLCare Pharmaceuticals, Inc.ANDACurrent